Rat EPCAM Protein (His Tag)

Produkt-Information von EPCAM Protein

QC Testing von EPCAM Protein

Purity	> 97 % as determined by SDS-PAGE	SDS-PAGE: EPCAM protein
Endotoxin	< 1.0 EU per μg of the protein as determined by the LAL method
Stability	Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal	Gln 24
Molecular Mass	The recombinant rat EPCAM comprises 254 amino acids and predicts a molecular mass of 29.2 kDa. The apparent molecular mass of  the recombinant protein is approximately 39 kDa in SDS-PAGE under reducing conditions due to glycosylation.
Formulation	Lyophilized from a 0.2μm filtered solution of PBS, pH7.4. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.

Usage Guide von EPCAM Protein

Verwandte Produkte & Themen von EPCAM Protein

Cancer>>Cancer Stem Cell (CSC)>>EpCAM/TROP-1/TACSTD1

Cancer>>Cancer Biomarkers>>EpCAM/TROP-1/TACSTD1

Immunology>>Adhesion Molecule>>Cell Adhesion Molecule (IgSF CAM)>>EpCAM/TROP-1/TACSTD1

Immunology>>Cluster of Differentiation>>Other>>EpCAM/TROP-1/TACSTD1/CD326

Beschreibung von EPCAM Protein

Epithelial Cell Adhesion Molecule (EpCAM), also known as GA733-2 antigen, is a type I transmembrane glycoprotein composed of an extracellular domain with two EGF-Like repeats and a cystenin-rich region, a transmembrane domain and a cytoplasmic domain. This protein is present in the majority of human epithelial cells and is highly expressed in gastrointestinal carcinomas. It has been shown to function as a calcium-independent homophilic cell adhesion molecule that does not exhibit any obvious relationship to the four known cell adhesion molecule superfamilies. Since the cell-cell adhesion is known to play an important role in tumor progression and metastasis, the high expression of GA733-2 antigen is associated with malignant tumor development in various types of cancer lesions. In addition, recent study revealed that EpCAM is the Wnt-beta-catenin signaling target gene and may be used to facilitate prognosis. EpCAM is being used as a target for immunotherapy treatment of human carcinomas.

References

1. Simon B. et al., 1990, Proc Natl Acad Sci. 87: 2755-9.
2. Chong JM. et al., 2001, J. Biol. Chem. 276: 5804 - 13.
3. Litvinov SV. et al., 1994, J Cell Biol. 125: 437-46.
4. Balzar M. et al., 1999. J Mol Med. 77: 699-712.
5. Yamashita T. et al., 2007, Cancer Res. 67: 10831-9.

Sino Biological Inc. liefert Rat EPCAM Protein (His Tag) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über Rat EPCAM Protein (His Tag) lesen Sie bitte: http://www.sinobiological.com/EPCAM-Protein-g-9323.html